Nurexone Biologic Eulerpool naujienos

Nurexone Biologic Eulerpool News

Nurexone Biologic akcijų naujienos

Nurexone Biologic stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Nurexone Biologic naujienas mes pateikiame čia.

• liepos 29 d. ·

  Yahoo
  NurExone Announces Further Expansion of ExoPTEN Patent Coverage
• liepos 17 d. ·

  Yahoo
  Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
• liepos 17 d. ·

  Yahoo
  Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
• liepos 5 d. ·

  Yahoo
  Updates from NurExone: Growth Conference Presentation and Website Relaunch
• birželio 28 d. ·

  Yahoo
  NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
• birželio 21 d. ·

  Yahoo
  On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
• birželio 11 d. ·

  Yahoo
  NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
• birželio 4 d. ·

  Yahoo
  NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
• gegužės 31 d. ·

  Yahoo
  Is NurExone Biologic (CVE:NRX) In A Good Position To Deliver On Growth Plans?
• gegužės 29 d. ·

  Yahoo
  NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials